DOCSLIB.ORG

Neurobiology of Aging

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neurobiology of Aging NEUROBIOLOGY OF AGING AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0197-4580 DESCRIPTION . Neurobiology of Aging publishes the results of studies in behavior, biochemistry, cell biology, endocrinology, molecular biology, morphology, neurology, neuropathology, pharmacology, physiology and protein chemistry in which the primary emphasis involves mechanisms of nervous system changes with age or diseases associated with age. Reviews and primary research articles are included, occasionally accompanied by open peer commentary. Letters to the Editor and brief communications are also acceptable. Brief reports of highly time-sensitive material are usually treated as rapid communications in which case editorial review is completed within six weeks and publication scheduled for the next available issue. The accepted abbreviation for Neurobiology of Aging for bibliographic citation is Neurobiol. Aging Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com Authors are also welcome to submit their manuscripts to the journal?s open access companion title, Aging Brain. AUDIENCE . Neuroscientists, Molecular Biologists, Gerontologists. IMPACT FACTOR . 2020: 4.673 © Clarivate Analytics Journal Citation Reports 2021 AUTHOR INFORMATION PACK 2 Oct 2021 www.elsevier.com/locate/neuaging 1 ABSTRACTING AND INDEXING . Current Contents - Life Sciences Elsevier BIOBASE Science Citation Index Embase BIOSIS Citation Index Research Alert PsycINFO PubMed/Medline Web of Science Scopus EDITORIAL BOARD . Editor-in-Chief Peter R. Rapp, Baltimore, Maryland, United States of America Managing Editor Pamela L. Yeh, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, United States of America Senior Editors Alzheimer's Disease & Other Dementias Ralph Nixon, Center for Dementia Research, Orangeburg, New York, United States of America Akihiko Takashima, Gakushuin University Faculty of Science Department of Life Sciences Laboratory for Alzheimer's Disease, Toshima, Japan Behavior, Cognition & Neurophysiology Michelle M. Adams, Bilkent University, Aysel Sabuncu Brain Research Center, Ankara, Turkey Genetic Reports Mark R. Cookson, National Institutes of Health, Bethesda, Maryland, United States of America Imaging Giovanni B. Frisoni, HUG and UniGeneva Intern Med-Psychaiatry, Geneve, Switzerland David J. Madden, Duke University Medical Center, School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina, United States of America Stress Signaling & Neuroplasticity Steven Barger, University of Arkansas for Medical Sciences Department of Neurobiology and Developmental Sciences, Little Rock, Arkansas, United States of America Structure Patrick R. Hof, Icahn School of Medicine at Mount Sinai, Nash Family Department of Neuroscience, New York, New York, United States Translational Preclinical and Clinical Research Raymond T. Bartus, RTBioconsultants, Inc., San Diego, California, United States of America Reviewing Editors Paul D. Coleman, Arizona State University, Tempe, Arizona, United States of America Brian T. Gold, University of Kentucky, Lexington, Kentucky, United States of America Alan A. Hartley, Scripps College, Claremont, California, United States of America M. Pievani, IRCCS S John of God Fatebenefratelli Centre, Brescia, Italy D.H. Salat, Athinoula A Martinos Center for Biomedical Imaging, Charlestown, Massachusetts, United States of America Julia Spaniol, Ryerson University Department of Psychology, Toronto, Ontario, Canada Editorial Advisory Board Jesus Avila, Madrid, Spain Heiko Braak, Ulm, Germany Ashley I. Bush, Parkville, Victoria, Australia Gemma Casadesus Smith, Kent, Ohio, United States of America Colin Combs, Grand Forks, North Dakota, United States of America AUTHOR INFORMATION PACK 2 Oct 2021 www.elsevier.com/locate/neuaging 2 Carl Cotman, Irvine, California, United States of America Charles DeCarli, Sacramento, California, United States of America Dennis Dickson, Jacksonville, Florida, United States of America Jianqing Ding, Shanghai, China James Eberwine, Philadelphia, Pennsylvania, United States of America Caleb Finch, Los Angeles, California, United States of America Dorothy Flood, West Chester, Pennsylvania, United States of America Pierluigi Gambetti, Cleveland, Ohio, United States of America Ezio Giacobini, Geneva, Switzerland Gunner K. Gouras, Lund, Sweden Karl Herrup, Cleveland, Ohio, New Jersey, United States of America Bradley Hyman, Boston, Massachusetts, United States of America Donald Ingram, Baton Rouge, Louisiana, United States of America Khalid Iqbal, Staten Island, New York, United States of America Terry Jernigan, La Jolla, California, United States of America Zaven Khachaturian, Bethesda, Maryland, United States of America Frank LaFerla, Irvine, California, United States of America Philip Landfield, Lexington, Kentucky, United States of America John H. Morrison, Davis, California, New York, United States of America Elliott Mufson, Phoenix, Arizona, Illinois, United States of America Giulio Pasinetti, New York, New York, United States of America Daniel Peterson, North Chicago, Illinois, United States of America Huntington Potter, Aurora, Colorado, United States of America Remi Quirion, Montreal, Quebec, Canada Joseph Rogers, Sun City, Arizona, United States of America Paul Sanberg, Tampa, Florida, United States of America Robert Sapolsky, Stanford, California, United States of America Michael Shelanski, New York, New York, United States of America J. Randall Slemmon, Titusville, New Jersey, Connecticut, United States of America David Smith, Oxford, United Kingdom Michael Sofroniew, Los Angeles, California, United States of America Alexis M. Stranahan, Augusta, Georgia, United States of America Dick Swaab, Amsterdam, Netherlands Rudolph Tanzi, Boston, Massachusetts, United States of America B.J. Traynor, Bethesda, Maryland, United States of America AUTHOR INFORMATION PACK 2 Oct 2021 www.elsevier.com/locate/neuaging 3 GUIDE FOR AUTHORS . AIMS AND SCOPE Neurobiology of Aging publishes the results of studies in behavior, biochemistry, cell biology, endocrinology, molecular biology, morphology, neurology, neuropathology, pharmacology, physiology and protein chemistry in which the primary emphasis involves mechanisms of nervous system changes with age or diseases associated with age. Only original articles will be accepted. Reviews and primary research articles are included, occasionally accompanied by open peer commentary. Letters to the Editor and brief communications are also acceptable. Brief reports of highly time-sensitive material are usually treated as rapid communications in which case editorial review is completed within 6 weeks and publication scheduled for the next available issue. Negative Results will be published as one journal page (3 double-spaced typed manuscript pages), with supplementary material to be posted at the journal website. Authors are referred to the following published editorial policy statements: Coleman, P.D. How old is old? Neurobiol. Aging 25:1;2004. Coleman, P.D.; Finch, C.E.; Joseph, J. The need for multiple time points in aging studies. Neurobiol. Aging 25:3-4;2004. Finch, C.E. Middle-age: An evolving frontier in gerontology. Neurobiol. Aging 12:1-2;1991. West, M.J. New stereological methods for counting neurons. Neurobiol. Aging 14:275-285;1993. West, M.J.; Coleman, P.D. How to count. Neurobiol. Aging 17:503;1996. Frisoni, G.B.; Coleman, P.D. Mild cognitive impairment: instructions for use at Neurobiology of Aging. Neurobiol. Aging 32:761-762;2011. GUIDELINES Genetic Analysis of Disease in the Era of Whole Genome Analysis and Public Databases. Over the past 5 years genetic analysis has changed almost beyond recognition. We now have the technology to assess association between any phenotype and alleles across the genome in a single analysis. Furthermore, these data are stored in publicly available databases such as dbGAP (www.ncbi.nlm.nih.gov/gap) and Alzgene (www.alzgene.org) where they are accessible and can be used in ongoing meta-analyses. In this environment, researchers should consider carefully the extent to which analyses they report substantively contribute to the literature. In the future, we will expect authors of any manuscripts submitted to access these databases before submission. While there are circumstances when limited analyses are appropriate, in general, clearly whole genome analyses are the way forward and there is no doubt that findings which come out of such studies are more reliable than those which come from candidate gene analyses. Additionally, we caution against the overinterpretation of analyses of secondary phenotypes (such as age of onset, or rate of cognitive decline). In studies where whole genome analyses are reported, we will always expect full summary statistics to be made available alongside the publication. We note that for many major phenotypes, there remain no whole genome reports. Clear examples include Alzheimer'??s disease in populations outside of Europeans. We would welcome such studies. Genetic Reports. It is our wish to provide
Load more

Recommended publications
  • Final Version
    REWARD LIST ‐ RANK C JCR 2018 ‐CiteScore 2018 WOS Edition/ Scopus Main Rank Subject Category Journal Title ISSN Subject Area code IEEE TRANSACTIONS ON ULTRASONICS SCIE ACOUSTICS 08853010 C FERROELECTRICS AND FREQUENCY SCIE ACOUSTICS JOURNAL OF VIBRATION AND CONTROL 10775463 C SCIE AGRICULTURAL ECONOMICS & POLICY JOURNAL OF AGRICULTURAL ECONOMICS 0021857X C SCIE AGRICULTURAL ENGINEERING BIOMASS & BIOENERGY 09619534 C SCIE AGRICULTURE, DAIRY & ANIMAL SCIENCE ANIMAL REPRODUCTION SCIENCE 03784320 C SCIE AGRICULTURE, DAIRY & ANIMAL SCIENCE APPLIED ANIMAL BEHAVIOUR SCIENCE 01681591 C SCIE AGRICULTURE, DAIRY & ANIMAL SCIENCE ARCHIVES OF ANIMAL NUTRITION 1745039X C JOURNAL OF ANIMAL PHYSIOLOGY AND SCIE AGRICULTURE, DAIRY & ANIMAL SCIENCE 09312439 C ANIMAL NUTRITION SCIE AGRICULTURE, DAIRY & ANIMAL SCIENCE Animals 20762615 C SCIE AGRICULTURE, MULTIDISCIPLINARY Journal of Land Use Science 1747423X C RENEWABLE AGRICULTURE AND FOOD SCIE AGRICULTURE, MULTIDISCIPLINARY 17421705 C SYSTEMS SCIE AGRICULTURE, MULTIDISCIPLINARY ANNALS OF APPLIED BIOLOGY 00034746 C SCIE AGRICULTURE, MULTIDISCIPLINARY CALIFORNIA AGRICULTURE 00080845 C SCIE AGRONOMY PLANT PATHOLOGY 00320862 C SCIE AGRONOMY IRRIGATION SCIENCE 03427188 C SCIE AGRONOMY Rice Science 16726308 C SCIE AGRONOMY Agronomy‐Basel 20734395 C SCIE AGRONOMY CROP PROTECTION 02612194 C SCIE AGRONOMY EXPERIMENTAL AGRICULTURE 00144797 C JOURNAL OF PLANT NUTRITION AND SOIL SCIE AGRONOMY 14368730 C SCIENCE SCIE ALLERGY CONTACT DERMATITIS 01051873 C SCIE ALLERGY Allergy Asthma & Immunology Research 20927355 C Advances
    [Show full text]
  • Journal of Aging Studies
    JOURNAL OF AGING STUDIES AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.2 • Guide for Authors p.3 ISSN: 0890-4065 DESCRIPTION . The Journal of Aging Studies features scholarly articles offering theoretically engaged interpretations that challenge existing theory and empirical work. Articles need not deal with the field of aging as a whole, but with any defensibly relevant topic pertinent to the aging experience and related to the broad concerns and subject matter of the social and behavioral sciences and the humanities. The journal emphasizes innovation and critique - new directions in general - regardless of theoretical or methodological orientation or academic discipline. Potential contributors are strongly advised to consult recent issues of the Journal for examples of articles that fit this mission. Further information for authors. The COVID-19 pandemic has resulted in both higher rates of submissions to JAS and much lower reviewer acceptance rates. In light of this, we ask two things of the community. First, patience with the longer lag time from submission to notification and reviewer comments. Second, if you submit a manuscript for consideration, then we hope you will do your part if asked to review for us in the future. Thank you for your understanding and help in ensuring the peer-review process continues as efficiently and robustly as possible in these trying times. IMPACT FACTOR . 2020: 2.078 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Research Alert Social Planning/Policy and Development Abstracts Social Sciences Citation Index Sociological Abstracts PsycINFO AgeLine Current Contents - Arts & Humanities Family Resources Scopus Abstracts in Social Gerontology Current Contents - Social & Behavioral Sciences PubMed/Medline AUTHOR INFORMATION PACK 24 Sep 2021 www.elsevier.com/locate/jaging 1 EDITORIAL BOARD .
    [Show full text]
  • SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total Journals: 8631
    SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total journals: 8631 1. 4OR-A QUARTERLY JOURNAL OF OPERATIONS RESEARCH 2. AAPG BULLETIN 3. AAPS JOURNAL 4. AAPS PHARMSCITECH 5. AATCC REVIEW 6. ABDOMINAL IMAGING 7. ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG 8. ABSTRACT AND APPLIED ANALYSIS 9. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 10. ACADEMIC EMERGENCY MEDICINE 11. ACADEMIC MEDICINE 12. ACADEMIC PEDIATRICS 13. ACADEMIC RADIOLOGY 14. ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE 15. ACCOUNTS OF CHEMICAL RESEARCH 16. ACCREDITATION AND QUALITY ASSURANCE 17. ACI MATERIALS JOURNAL 18. ACI STRUCTURAL JOURNAL 19. ACM COMPUTING SURVEYS 20. ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS 21. ACM SIGCOMM COMPUTER COMMUNICATION REVIEW 22. ACM SIGPLAN NOTICES 23. ACM TRANSACTIONS ON ALGORITHMS 24. ACM TRANSACTIONS ON APPLIED PERCEPTION 25. ACM TRANSACTIONS ON ARCHITECTURE AND CODE OPTIMIZATION 26. ACM TRANSACTIONS ON AUTONOMOUS AND ADAPTIVE SYSTEMS 27. ACM TRANSACTIONS ON COMPUTATIONAL LOGIC 28. ACM TRANSACTIONS ON COMPUTER SYSTEMS 29. ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION 30. ACM TRANSACTIONS ON DATABASE SYSTEMS 31. ACM TRANSACTIONS ON DESIGN AUTOMATION OF ELECTRONIC SYSTEMS 32. ACM TRANSACTIONS ON EMBEDDED COMPUTING SYSTEMS 33. ACM TRANSACTIONS ON GRAPHICS 34. ACM TRANSACTIONS ON INFORMATION AND SYSTEM SECURITY 35. ACM TRANSACTIONS ON INFORMATION SYSTEMS 36. ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY 37. ACM TRANSACTIONS ON INTERNET TECHNOLOGY 38. ACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA 39. ACM TRANSACTIONS ON MATHEMATICAL SOFTWARE 40. ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION 41. ACM TRANSACTIONS ON MULTIMEDIA COMPUTING COMMUNICATIONS AND APPLICATIONS 42. ACM TRANSACTIONS ON PROGRAMMING LANGUAGES AND SYSTEMS 43. ACM TRANSACTIONS ON RECONFIGURABLE TECHNOLOGY AND SYSTEMS 44.
    [Show full text]
  • Jennifer I. Luebke 1 Curriculum Vitae Jennifer I. Luebke, Ph.D. Associate
    Jennifer I. Luebke Curriculum Vitae Jennifer I. Luebke, Ph.D. Associate Professor of Anatomy & Neurobiology Associate Professor of Psychiatry Director, Laboratory of Cellular Neurobiology Boston University School of Medicine 85 East Newton Street, M949 Boston, Massachusetts 02118 Voice: 617-638-4930 Email: [email protected] Education and Employment History: 1980-1984: B.S. (Biology) Randolph-Macon College, Ashland, Virginia 1984-1986: Laboratory Technician (Laboratory of Cell Biology and Genetics, NIDDK) National Institutes of Health, Bethesda, Maryland 1986-1990: Ph.D. Student (Anatomy & Neurobiology), Boston University School of Medicine, Boston, Massachusetts (Linda L. Wright, mentor) 1990-1992: Postdoctoral Fellow, Department of Psychiatry, Harvard Medical School, Boston, Massachusetts (Robert W. McCarley and Robert W. Greene mentors) 1992-1995: Postdoctoral Fellow, Department of Physiology, Tufts University Medical School, Boston, Massachusetts (Kathleen Dunlap, mentor) 1995-2003: Assistant Professor, Department of Anatomy & Neurobiology and Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts 2004-Present: Associate Professor, Department of Anatomy & Neurobiology and Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts 2010-Present: Adjunct Associate Professor, Department of Neuroscience, Mount Sinai School of Medicine, New York, New York Research Summary: Research is directed toward understanding alterations in the structure and function of individual cortical pyramidal cells in a rhesus monkey model of normal aging and in transgenic mouse models of neurodegenerative disease. Using whole-cell patch-clamp methods and ultra-high resolution confocal microscopy, Dr. Luebke has demonstrated marked alterations in action potential firing patterns (and underlying ionic currents), glutamatergic and GABAergic synaptic response properties and detailed dendritic and spine architecture in cortical pyramidal cells both in normal aging and in mouse models of neurodegenerative disease.
    [Show full text]
  • Predicting Cognitive Decline: Genetic, Environmental and Lifestyle Risk Factors
    Predicting Cognitive Decline: Genetic, Environmental and Lifestyle Risk Factors Shea J. Andrews April 2017 A thesis by compilation submitted for the degree of Doctor of Philosophy of The Australian National University © Copyright by Shea John Frederick Andrews 2017 All Rights Reserved i Declaration This work was conducted from February 2013 to August 2016 at the Genome Diversity and Health Group, John Curtin School of Medical Research, The Australian National University, Canberra, ACT. This thesis by compilation consists of five original publications describing the analyses I have performed during my candidature investigating the role of genetic, environmental and lifestyle risk factors in normal cognitive aging. All five publications have been published in Q1 ranked journals according to the SCImago Journal & Country Rankings in the fields of neurology, genetics, psychiatry and mental health, and geriatric and gerontology. My specific contribution to each manuscript is detailed in the subsequent pages in the form of a statement signed by the senior author of each publication. This document has not been submitted for qualifications at any other academic institution. Shea Andrews Canberra, Australia April 2017 ii Published Papers Andrews, SJ, Das, D., Anstey, KJ., Easteal, S. (2015). Interactive effect of APOE genotype and blood pressure on cognitive decline: The PATH through life project. Journal of Alzheimer's Disease. 44(4): 1087-98. DOI: 10.3233/JAD- 140630 For this publication, I designed and performed all statistical analyses and wrote the manuscript. A slightly modified version of this paper is presented in Chapter 3. ____________________ Simon Easteal Senior Author April 2017 Andrews SJ, Das D, Cherbuin N, Anstey KJ, Easteal S.
    [Show full text]
  • Brain Ageing in the New Millennium
    Brain ageing in the new millennium Julian N. Trollor, Michael J. Valenzuela Objective: This paper examines the current literature pertaining to brain ageing. The objective of this review is to provide an overview of the effects of ageing on brain structure and function and to examine possible mediators of these changes. Methods: A MEDLINE search was conducted for each area of interest. A selective review was undertaken of relevant articles. Results: Although fundamental changes in fluid intellectual abilities occur with age, global cognitive decline is not a hallmark of the ageing process. Decline in fluid intellectual ability is paralleled by regionally specific age related changes apparent from both structural and functional neuroimaging studies. The histopathological mediators of these changes do not appear to be reduction in neuronal number, which, with the exception of selected hippo- campal regions, remain relatively stable across age. At the molecular level, several mech- anisms of age related change have been postulated. Such theoretical models await refinement and may eventually provide a basis for therapy designed to reduce effects of the ageing process. The role of possible protective factors such as ‘brain reserve’, neuro- protective agents and hormonal factors in modifying individual vulnerability to the ageing process has been the focus of a limited number of studies. Conclusion: Our understanding of the functional and structural changes associated with both healthy and pathological ageing is rapidly gaining in sophistication and complexity. An awareness of the fundamental biological substrates underpinning the ageing process will allow improved insights into vulnerability to neuropsychiatric disease associated with advancing age. Key words: brain ageing, cognition, dementia, neuroimaging.
    [Show full text]
  • The Effects of Normal Aging on Myelin and Nerve Fibers: a Review∗
    Journal of Neurocytology 31, 581–593 (2002) The effects of normal aging on myelin and nerve fibers: A review∗ ALAN PETERS Department of Anatomy and Neurobiology, Boston University School of Medicine, 715, Albany Street, Boston, MA 02118, USA [email protected] Received 7 January 2003; revised 4 March 2003; accepted 5 March 2003 Abstract It was believed that the cause of the cognitive decline exhibited by human and non-human primates during normal aging was a loss of cortical neurons. It is now known that significant numbers of cortical neurons are not lost and other bases for the cognitive decline have been sought. One contributing factor may be changes in nerve fibers. With age some myelin sheaths exhibit degenerative changes, such as the formation of splits containing electron dense cytoplasm, and the formation on myelin balloons. It is suggested that such degenerative changes lead to cognitive decline because they cause changes in conduction velocity, resulting in a disruption of the normal timing in neuronal circuits. Yet as degeneration occurs, other changes, such as the formation of redundant myelin and increasing thickness suggest of sheaths, suggest some myelin formation is continuing during aging. Another indication of this is that oligodendrocytes increase in number with age. In addition to the myelin changes, stereological studies have shown a loss of nerve fibers from the white matter of the cerebral hemispheres of humans, while other studies have shown a loss of nerve fibers from the optic nerves and anterior commissure in monkeys. It is likely that such nerve fiber loss also contributes to cognitive decline, because of the consequent decrease in connections between neurons.
    [Show full text]
  • Technology and Aging in America (Part 14 Of
    Appendix B The Cell Biology of Aging Introduction spans that seem to be “programmed” into them accord- ing to species. Mechanisms underlying this programmed The distinction between the effects of aging as a aging could involve an intrinsic genetic component of chronological process and diseases whose prevalence the tissues (24), and/or an extrinsic “neuroendocrine increase with advancing age remains blurred. Condi- pacemaker” (16,17). tions once thought to be inevitable companions of old The genetic version of the biological clock is bol- age are now known to in fact be pathological in origin stered by the observation that the survival time of and thus possibly treatable and preventable. One ex- tissues grafted (or transferred) from an older animal ample is senile dementia, no longer the mysterious fate into a younger one of the same species seems to de- of the very old, but often a clinical manifestation of pend on the age of the donor and is not influenced arteriosclerotic or biochemical brain disease. by the “younger” environment into which it has been Further research may elucidate the mechanisms introduced (24). Similarly, when nuclei from younger underlying aging and their possible connection to age- cells are transplanted into the cytoplasm of older cells, related diseases, leading to the development of medi- the recipients then live longer and regain the ability cal techniques that delay the onset and progression to replicate. These observations all suggest that a of symptoms. While it may not lead to actual exten- “clock” controlling aging does exist and may be located sion of the human life span, such knowledge could re- in the nucleus, possibly in the genetic material (24).
    [Show full text]
  • Integrated Transcriptomic and Neuroimaging Brain Model Decodes
    RESEARCH ARTICLE Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer’s disease Quadri Adewale1,2,3, Ahmed F Khan1,2,3, Felix Carbonell4, Yasser Iturria-Medina1,2,3*, Alzheimer’s Disease Neuroimaging Initiative† 1Neurology and Neurosurgery Department, Montreal Neurological Institute, McGill University, Montreal, Canada; 2McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada; 3Ludmer Centre for Neuroinformatics and Mental Health, McGill University, Montreal, Canada; *For correspondence: 4Biospective Inc, Montreal, Canada [email protected] †Data used in preparation of this article were partly obtained from the Alzheimer’s Disease Abstract Both healthy aging and Alzheimer’s disease (AD) are characterized by concurrent Neuroimaging Initiative (ADNI) alterations in several biological factors. However, generative brain models of aging and AD are database (adni.loni.usc.edu). As limited in incorporating the measures of these biological factors at different spatial resolutions. such, the investigators within the Here, we propose a personalized bottom-up spatiotemporal brain model that accounts for the ADNI contributed to the design direct interplay between hundreds of RNA transcripts and multiple macroscopic neuroimaging and implementation of ADNI modalities (PET, MRI). In normal elderly and AD participants, the model identifies top genes and/or provided data but did not modulating tau and amyloid-b burdens, vascular flow, glucose metabolism, functional activity, and participate in analysis or writing atrophy to drive cognitive decline. The results also revealed that AD and healthy aging share of this report. A complete listing specific biological mechanisms, even though AD is a separate entity with considerably more altered of ADNI investigators can be pathways.
    [Show full text]
  • Download Download
    NeuroRegulation The Official Journal of . Volume 8, Number 1, 2021 NeuroRegulation Editor-in-Chief Rex L. Cannon, PhD: SPESA Research Institute, Knoxville, TN, USA Executive Editor Nancy L. Wigton, PhD: 1) Grand Canyon University, Phoenix, AZ, USA; 2) Applied Neurotherapy Center, Tempe, AZ, USA Associate Editors Scott L. Decker, PhD: University of South Carolina, Department of Psychology, Columbia, SC, USA Jon A. Frederick, PhD: Lamar University, Beaumont, TX, USA Genomary Krigbaum, PsyD: University of Wyoming, Family Medicine Residency, Casper, WY, USA Randall Lyle, PhD: Mount Mercy University, Cedar Rapids, IA, USA Tanya Morosoli, MSc: 1) Clínica de Neuropsicología Diagnóstica y Terapéutica, Mexico City, Mexico; 2) ECPE, Harvard T. H. Chan School oF Public Health, Boston, MA, USA Sarah Prinsloo, PhD: MD Anderson Cancer Center, Houston, TX, USA Deborah Simkin, MD: 1) Emory University School of Medicine, Department of Psychiatry, Atlanta, GA, USA; 2) Attention, Memory, and Cognition Center, Destin, FL, USA Estate M. Sokhadze, PhD: University of South Carolina, School of Medicine Greenville, Greenville, SC, USA Larry C. Stevens, PhD: Northern Arizona University, Department of Psychological Services, Flagstaff, AZ, USA Tanju Surmeli, MD: Living Health Center for Research and Education, Sisli, Istanbul, Turkey Production Editor Jacqueline Luk Paredes, Phoenix, AZ, USA NeuroRegulation (ISSN: 2373-0587) is published quarterly by the International Society for Neurofeedback and Research (ISNR), 13876 SW 56th Street, PMB 311, Miami, FL 33175-6021, USA. Copyright NeuroRegulation is open access with no submission fees or APC (Author Processing Charges). This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
    [Show full text]
  • Evidence Portfolio, Aging Subcommittee, Physical Function
    Evidence Portfolio – Aging Subcommittee, Question 2 What is the relationship between physical activity and physical function among the general aging population? a. Is there a dose-response relationship? If yes, what is the shape of the relationship? b. Does the relationship vary by age, sex, race/ethnicity, socio-economic status, or weight status? c. What type(s) of physical activity are effective for improving or maintaining physical function? d. What impairment(s) modify the relationship between physical activity and physical function among the general aging population? Sources of Evidence: Existing Systematic Reviews, Meta-Analyses, and Pooled Analysis Conclusion Statements and Grades Strong evidence demonstrates that physical activity improves physical function and reduces risk of age- related loss of physical function in the general aging population. PAGAC Grade: Strong. Strong evidence demonstrates an inverse dose-response relationship between volume of aerobic physical activity and risk of physical functional limitations in the general aging population. PAGAC Grade: Strong. Limited evidence suggests an inverse dose-response relationship of volume of muscle-strengthening and frequency of balance training with risk of physical functional limitations in the general aging population. PAGAC Grade: Limited. Limited evidence suggests that the relationship between physical activity and physical function does not vary by age, sex, or weight status in the general population of older adults. PAGAC Grade: Limited. Insufficient evidence is available to determine whether the relationship between physical activity and physical function varies by race/ethnicity and socioeconomic status in the general population of older adults. PAGAC Grade: Not assignable. Strong evidence demonstrates that aerobic, muscle-strengthening, and multicomponent physical activity improves physical function in the general aging population.
    [Show full text]
  • Aging and Health Research
    AGING AND HEALTH RESEARCH AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 2667-0321 DESCRIPTION . Aims Aging and Health Research (AHR) is an international, peer-reviewed open access journal that publishes articles from a global research community. The aims of this journal is to establish an innovative forum of global aging and health research to advance knowledge in diverse disciplines to promote early detection, diagnosis, treatment, and intervention of chronic diseases; to disseminating knowledge for optimal translation of research findings into policy and practical settings; to communicate new ideas, findings, perspectives, and research directions; to advocate public policies promoting aging and health in a global context. Scope Aging and Health Research (AHR) welcomes the submission of original and review articles, short communications and perspectives/commentaries. The topics of this journal are relevant to interdisciplinary investigations, integrative and translational articles, related to: diagnosis, treatment, etiology, risk factors, early detection, prognosis, clinical interventions, prevention, and new models of health services in aging related diseases and health status. An online-only journal, AHR is focused on pharmacology, nursing, epidemiology, public health, dentistry, behavior, neurology, psychiatry, gerontology, geriatrics, social work, global health, sociology, allied health, health services research, health economics, political science, and public policy. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Editor in Chief Ding Ding, Fudan University, Shanghai, China Population-based and hospital-based epidemiological studies of neurological diseases (such as stroke, dementia, epilepsy, Parkinson's disease, essential trauma, migraine and autism), including etiology, risk factors, prognosis, genetic, biomarkers, intervention, big-data analysis, health economic analysis.
    [Show full text]